U.S. Portable Ventilator Market by Mode, (Pressure Mode Ventilation, Volume Mode Ventilation and Others), Interface (Invasive Ventilator and Non-Invasive Ventilator), Age Group (Pediatric & Neonatal, Adult and Geriatric), and End User (Hospitals & Clinics, Ambulatory Care Centers and Homecare): Opportunity Analysis and Industry Forecast, 2020–2027
The U.S. portable ventilator market was valued at $106.20 million in 2019 and is estimated to reach $160.98 million by 2027 at a CAGR of 5.3% from 2019 to 2027.
Portable ventilators are used to provide oxygen to patients while commuting. The factors that drive the market are increasing breathing issues and respiratory problems among the growing population. Additionally, increasing smoking population is another factor for the growth in demand for portable ventilators. The intervention of technology in the healthcare sector has improved the operational conduct and has provided the patients with intensive care solutions.
It is a form of breathing assistance in which a patient is connected to a machine through an endotracheal tube directly applied to the airway or non-invasive (NIV) mask. It is also employed as a diagnostic tool to measure static compliance of airway resistance and irregular functioning of respiratory system.
Increase in incidences of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, bronchitis, and other lung disorders, and rise in number of accidental emergencies lead to substantial requirement of portable ventilators. In addition, growth in geriatric population prone to respiratory emergencies is one of the key drivers of the market. Moreover, technological innovations in respiratory care devices, namely, non-invasive ventilation technology and portable ventilators, further supplement the market growth. Rise in preference of portable and home care ventilations for long-term ventilated patients is expected to be another major factor influencing the market growth. On the contrary, injuries associated with invasive mechanical ventilation such as pneumonia, lung injury, and barotrauma and high cost of portable ventilators are the prime factors that restrict the market growth.
The U.S. portable ventilators market is segmented on the basis of age group, interface, mode, and end user. On the basis of mode, it is classified into pressure-mode ventilation, volume-mode ventilation, and others.
On the basis of interface, the market is divided into invasive ventilation and non-invasive ventilation. Invasive ventilators are specifically designed for critically ill patients suffering from respiratory failure, congestive cardiac failure, and for newborns. The Invasive ventilators segment is expected to grow at a rapid pace as these ventilators are convenient for patients, have less side effects, and faster recovery.
On the basis of age group, the market is categorized into pediatric & neonatal, adult and geriatric. By end user, it is segmented into hospital and clinic, home care, and ambulatory care centers.
The key players operating in the U.S. portable ventilator market include Koninklijke Philips N.V., Drgerwerk AG and CO., Becton, Dickinson And Company, Getinge AB, Resmed Inc., Percussionaire Corp., Smiths Group Plc., Hamilton Medical, Medtronic Plc. and Zoll Corporation.
KEY BENEFITS FOR STAKEHOLDERS
Portable ventilators are used to provide oxygen to patients while commuting. The factors that drive the market are increasing breathing issues and respiratory problems among the growing population. Additionally, increasing smoking population is another factor for the growth in demand for portable ventilators. The intervention of technology in the healthcare sector has improved the operational conduct and has provided the patients with intensive care solutions.
It is a form of breathing assistance in which a patient is connected to a machine through an endotracheal tube directly applied to the airway or non-invasive (NIV) mask. It is also employed as a diagnostic tool to measure static compliance of airway resistance and irregular functioning of respiratory system.
Increase in incidences of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, bronchitis, and other lung disorders, and rise in number of accidental emergencies lead to substantial requirement of portable ventilators. In addition, growth in geriatric population prone to respiratory emergencies is one of the key drivers of the market. Moreover, technological innovations in respiratory care devices, namely, non-invasive ventilation technology and portable ventilators, further supplement the market growth. Rise in preference of portable and home care ventilations for long-term ventilated patients is expected to be another major factor influencing the market growth. On the contrary, injuries associated with invasive mechanical ventilation such as pneumonia, lung injury, and barotrauma and high cost of portable ventilators are the prime factors that restrict the market growth.
The U.S. portable ventilators market is segmented on the basis of age group, interface, mode, and end user. On the basis of mode, it is classified into pressure-mode ventilation, volume-mode ventilation, and others.
On the basis of interface, the market is divided into invasive ventilation and non-invasive ventilation. Invasive ventilators are specifically designed for critically ill patients suffering from respiratory failure, congestive cardiac failure, and for newborns. The Invasive ventilators segment is expected to grow at a rapid pace as these ventilators are convenient for patients, have less side effects, and faster recovery.
On the basis of age group, the market is categorized into pediatric & neonatal, adult and geriatric. By end user, it is segmented into hospital and clinic, home care, and ambulatory care centers.
The key players operating in the U.S. portable ventilator market include Koninklijke Philips N.V., Drgerwerk AG and CO., Becton, Dickinson And Company, Getinge AB, Resmed Inc., Percussionaire Corp., Smiths Group Plc., Hamilton Medical, Medtronic Plc. and Zoll Corporation.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2027, which assists in identifying prevailing market opportunities.
- An in-depth analysis of various regions is likely to provide a detailed understanding of the current trends to the stakeholders to formulate region-specific plans.
- Comprehensive analysis of factors that drive and restrain growth of the portable ventilator market are provided.
- A deep dive analysis of U.S. provides insights that would allow companies to strategically plan their business moves.
- By Mode
- Pressure mode ventilation
- Volume mode ventilation
- Others
- By Interface
- Invasive ventilator
- Non-invasive ventilator
- By Age Group
- Pediatric & neonatal
- Adult
- Geriatric
- By End User
- Hospital and clinic
- Ambulatory care centers
- Home care
- Becton, Dickinson And Company
- Drgerwerk AG and CO.
- GETINGE AB
- Hamilton Medical
- Koninklijke Philips N.V.
- Medtronic Plc.
- Percussionaire Corp.
- Resmed Inc.
- Smith’s Group Plc.
- Zoll Corporation (subsidary of Asahi Kasei Group)
CHAPTER 1:INTRODUCTION
1.1.Report description16
1.2.Key benefits for stakeholders18
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.1.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top player positioning
3.3.Top winning strategies
3.4.Porter’s five forces analysis
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Growth in geriatric population
3.5.1.2.High prevalence of chronic respiratory diseases
3.5.1.3.Increase in government expenditures on healthcare
3.5.2.Restraints
3.5.2.1.High cost of portable ventilators
3.5.2.2.Rise in incidences of ventilator-associated pneumonia
3.5.3.Opportunity
3.5.3.1.Technological innovations, portability, and design
3.6.COVID-19 impact analysis for portable ventilator market
CHAPTER 4:U.S PORTABLE VENTILATORS MARKET, BY MODE
4.1.Overview
4.1.1.Market size and forecast
4.2.Pressure Mode Ventilation
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.3.Volume Mode Ventilation
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.4.Others
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
CHAPTER 5:U.S. PORTABLE VENTILATOR MARKET, BY INTERFACE
5.1.Overview
5.1.1.Market size and forecast
5.2.Non-Invasive ventilation
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast
5.3.Invasive Ventilation
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast
CHAPTER 6:U.S PORTABLE VENTILATOR MARKET, BY AGE GROUP
6.1.Overview
6.1.1.Market size and forecast
6.2.Pediatric & neonatal
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast
6.3.Adult
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast
6.4.Geriatric
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast
CHAPTER 7:U.S. PORTABLE VENTILATORS MARKET, BY END USER
7.1.Overview
7.1.1.Market size and forecast
7.2.Hospital and clinics
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast
7.3.Ambulatory care center
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast
7.4.Home Care
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast
CHAPTER 8:COMPANY PROFILES
8.1.BECTON, DICKINSON AND COMPANY (CAREFUSION/ VYAIRE MEDICAL INC.)
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.2.DRAEGERWERK AG & CO. KGAA
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.3.GETINGE AB
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.4.HAMILTON MEDICAL AG
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Product portfolio
8.4.4.Key strategic moves and developments
8.5.KONINKLIJKE PHILIPS N.V.
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.MEDTRONIC PLC. (COVIDIEN LTD.)
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments
8.7.PERCUSSIONAIRE CORP.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.8.SMITHS GROUP PLC.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.RESMED INC.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.10.ZOLL MEDICAL CORPORATION
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Key strategic moves and developments
1.1.Report description16
1.2.Key benefits for stakeholders18
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.1.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top player positioning
3.3.Top winning strategies
3.4.Porter’s five forces analysis
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Growth in geriatric population
3.5.1.2.High prevalence of chronic respiratory diseases
3.5.1.3.Increase in government expenditures on healthcare
3.5.2.Restraints
3.5.2.1.High cost of portable ventilators
3.5.2.2.Rise in incidences of ventilator-associated pneumonia
3.5.3.Opportunity
3.5.3.1.Technological innovations, portability, and design
3.6.COVID-19 impact analysis for portable ventilator market
CHAPTER 4:U.S PORTABLE VENTILATORS MARKET, BY MODE
4.1.Overview
4.1.1.Market size and forecast
4.2.Pressure Mode Ventilation
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.3.Volume Mode Ventilation
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.4.Others
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
CHAPTER 5:U.S. PORTABLE VENTILATOR MARKET, BY INTERFACE
5.1.Overview
5.1.1.Market size and forecast
5.2.Non-Invasive ventilation
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast
5.3.Invasive Ventilation
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast
CHAPTER 6:U.S PORTABLE VENTILATOR MARKET, BY AGE GROUP
6.1.Overview
6.1.1.Market size and forecast
6.2.Pediatric & neonatal
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast
6.3.Adult
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast
6.4.Geriatric
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast
CHAPTER 7:U.S. PORTABLE VENTILATORS MARKET, BY END USER
7.1.Overview
7.1.1.Market size and forecast
7.2.Hospital and clinics
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast
7.3.Ambulatory care center
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast
7.4.Home Care
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast
CHAPTER 8:COMPANY PROFILES
8.1.BECTON, DICKINSON AND COMPANY (CAREFUSION/ VYAIRE MEDICAL INC.)
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.2.DRAEGERWERK AG & CO. KGAA
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.3.GETINGE AB
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.4.HAMILTON MEDICAL AG
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Product portfolio
8.4.4.Key strategic moves and developments
8.5.KONINKLIJKE PHILIPS N.V.
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.MEDTRONIC PLC. (COVIDIEN LTD.)
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments
8.7.PERCUSSIONAIRE CORP.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.8.SMITHS GROUP PLC.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.RESMED INC.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.10.ZOLL MEDICAL CORPORATION
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Key strategic moves and developments
LIST OF TABLES
TABLE 01.U.S PORTABLE VENTILATORS MARKET, BY MODE, 2019–2027 ($MILLION)5
TABLE 02.U.S. PORTABLE VENTILATOR MARKET, BY INTERFACE, 2019–2027 ($MILLION)
TABLE 03.U.S. PORTABLE VENTILATORS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 04.U.S. PORTABLE VENTILATORS MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 05.BD: COMPANY SNAPSHOT
TABLE 06.BD: OPERATING SEGMENTS
TABLE 07.BD: PRODUCT PORTFOLIO
TABLE 08.DRAGER: COMPANY SNAPSHOT
TABLE 09.DRAGER: PRODUCT PORTFOLIO
TABLE 10.GETINGE: COMPANY SNAPSHOT
TABLE 11.GETINGE AB: OPERATING SEGMENT
TABLE 12.GETINGE: PRODUCT PORTFOLIO
TABLE 13.HAMILTON: COMPANY SNAPSHOT
TABLE 14.HAMILTON: PRODUCT PORTFOLIO
TABLE 15.PHILIPS: COMPANY SNAPSHOT
TABLE 16.PHILIPS: OPERATING SEGMENTS
TABLE 17.PHILIPS: PRODUCT PORTFOLIO
TABLE 18.MEDTRONIC: COMPANY SNAPSHOT
TABLE 19.MEDTRONIC: OPERATING SEGMENTS
TABLE 20.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 21.PERCUSSIONAIRE: COMPANY SNAPSHOT
TABLE 22.PERCUSSIONAIRE: OPERATING SEGMENTS
TABLE 23.PERCUSSIONAIRE: PRODUCT PORTFOLIO
TABLE 24.SMITHS: COMPANY SNAPSHOT
TABLE 25.SMITHS: OPERATING SEGMENTS
TABLE 26.SMITHS: PRODUCT PORTFOLIO
TABLE 27.RESMED: COMPANY SNAPSHOT
TABLE 28.RESMED: OPERATING SEGMENTS
TABLE 29.RESMED: PRODUCT PORTFOLIO
TABLE 30.ZOLL: COMPANY SNAPSHOT
TABLE 31.ZOLL: OPERATING SEGMENTS
TABLE 32.ZOLL: PRODUCT PORTFOLIO
TABLE 01.U.S PORTABLE VENTILATORS MARKET, BY MODE, 2019–2027 ($MILLION)5
TABLE 02.U.S. PORTABLE VENTILATOR MARKET, BY INTERFACE, 2019–2027 ($MILLION)
TABLE 03.U.S. PORTABLE VENTILATORS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 04.U.S. PORTABLE VENTILATORS MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 05.BD: COMPANY SNAPSHOT
TABLE 06.BD: OPERATING SEGMENTS
TABLE 07.BD: PRODUCT PORTFOLIO
TABLE 08.DRAGER: COMPANY SNAPSHOT
TABLE 09.DRAGER: PRODUCT PORTFOLIO
TABLE 10.GETINGE: COMPANY SNAPSHOT
TABLE 11.GETINGE AB: OPERATING SEGMENT
TABLE 12.GETINGE: PRODUCT PORTFOLIO
TABLE 13.HAMILTON: COMPANY SNAPSHOT
TABLE 14.HAMILTON: PRODUCT PORTFOLIO
TABLE 15.PHILIPS: COMPANY SNAPSHOT
TABLE 16.PHILIPS: OPERATING SEGMENTS
TABLE 17.PHILIPS: PRODUCT PORTFOLIO
TABLE 18.MEDTRONIC: COMPANY SNAPSHOT
TABLE 19.MEDTRONIC: OPERATING SEGMENTS
TABLE 20.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 21.PERCUSSIONAIRE: COMPANY SNAPSHOT
TABLE 22.PERCUSSIONAIRE: OPERATING SEGMENTS
TABLE 23.PERCUSSIONAIRE: PRODUCT PORTFOLIO
TABLE 24.SMITHS: COMPANY SNAPSHOT
TABLE 25.SMITHS: OPERATING SEGMENTS
TABLE 26.SMITHS: PRODUCT PORTFOLIO
TABLE 27.RESMED: COMPANY SNAPSHOT
TABLE 28.RESMED: OPERATING SEGMENTS
TABLE 29.RESMED: PRODUCT PORTFOLIO
TABLE 30.ZOLL: COMPANY SNAPSHOT
TABLE 31.ZOLL: OPERATING SEGMENTS
TABLE 32.ZOLL: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.U.S. PORTABLE VENTILATOR MARKET SEGMENTATION
FIGURE 02.TOP PLAYER POSTIONING, 2019
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017–2020*
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2020* (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017–2020*
FIGURE 06.MODERATE BARGAINING POWER OF BUYERS
FIGURE 07.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 08.HIGH THREAT OF NEW ENTRANTS
FIGURE 09.MODERATE THREAT OF SUBSTITUTION
FIGURE 10.HIGH COMPETITIVE RIVALRY
FIGURE 11.U.S. PORTABLE VENTILATOR MARKET FOR PRESSURE MODE VENTILATION, 2019-2027 ($MILLION)
FIGURE 12.U.S. PORTABLE VENTILATOR MARKET FOR VOLUME MODE VENTILATION, 2019-2027 ($MILLION)
FIGURE 13.U.S. PORTABLE VENTILATOR MARKET FOR OTHERS, 2019-2027 ($MILLION)
FIGURE 14.U.S. PORTABLE VENTILATOR MARKET FOR NON-INVASIVE VENTILATION, 2019-2027 ($MILLION)
FIGURE 15.U.S. PORTABLE VENTILATOR MARKET FOR INVASIVE VENTILATION, 2019-2027 ($MILLION)
FIGURE 16.U.S. PORTABLE VENTILATOR MARKET FOR PEDIATRIC & NEONATAL, 2019-2027 ($MILLION)
FIGURE 17.U.S. PORTABLE VENTILATOR MARKET ADULT, 2019-2027 ($MILLION)
FIGURE 18.U.S. PORTABLE VENTILATOR MARKET FOR GERIATRIC, 2019-2027 ($MILLION)
FIGURE 19.U.S. PORTABLE VENTILATOR MARKET FOR HOSPITAL AND CLINICS, 2019-2027 ($MILLION)
FIGURE 20.U.S. PORTABLE VENTILATOR MARKET FOR AMBULATORY CARE CENTER, 2019-2027 ($MILLION)
FIGURE 21.U.S. PORTABLE VENTILATOR MARKET FOR HOME CARE, 2019-2027 ($MILLION)
FIGURE 22.BD: NET SALES, 2017–2019 ($MILLION)
FIGURE 23.BD: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 24.BD: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 25.DRAGER: REVENUE, 2017–2019 ($MILLION)
FIGURE 26.DRAGER: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 27.GETINGE: REVENUE, 2017–2019 ($MILLION)82
FIGURE 28.GETINGE: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 29.GETINGE: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 30.PHILIPS: NET SALES, 2017–2019 ($MILLION)
FIGURE 31.PHILIPS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 32.PHILIPS: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 33.MEDTRONIC: NET SALES, 2017–2019 ($MILLION)
FIGURE 34.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 35.MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 36.SMITHS: NET SALES, 2017–2019 ($MILLION)101
FIGURE 37.SMITHS: REVENUE SHARE, BY DIVISION, 2019 (%)
FIGURE 38.SMITHS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 39.RESMED: NET SALES, 2017–2019 ($MILLION)106
FIGURE 40.RESMED: REVENUE SHARE, BY DIVISION, 2019 (%)
FIGURE 41.RESMED: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 01.U.S. PORTABLE VENTILATOR MARKET SEGMENTATION
FIGURE 02.TOP PLAYER POSTIONING, 2019
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017–2020*
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2020* (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017–2020*
FIGURE 06.MODERATE BARGAINING POWER OF BUYERS
FIGURE 07.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 08.HIGH THREAT OF NEW ENTRANTS
FIGURE 09.MODERATE THREAT OF SUBSTITUTION
FIGURE 10.HIGH COMPETITIVE RIVALRY
FIGURE 11.U.S. PORTABLE VENTILATOR MARKET FOR PRESSURE MODE VENTILATION, 2019-2027 ($MILLION)
FIGURE 12.U.S. PORTABLE VENTILATOR MARKET FOR VOLUME MODE VENTILATION, 2019-2027 ($MILLION)
FIGURE 13.U.S. PORTABLE VENTILATOR MARKET FOR OTHERS, 2019-2027 ($MILLION)
FIGURE 14.U.S. PORTABLE VENTILATOR MARKET FOR NON-INVASIVE VENTILATION, 2019-2027 ($MILLION)
FIGURE 15.U.S. PORTABLE VENTILATOR MARKET FOR INVASIVE VENTILATION, 2019-2027 ($MILLION)
FIGURE 16.U.S. PORTABLE VENTILATOR MARKET FOR PEDIATRIC & NEONATAL, 2019-2027 ($MILLION)
FIGURE 17.U.S. PORTABLE VENTILATOR MARKET ADULT, 2019-2027 ($MILLION)
FIGURE 18.U.S. PORTABLE VENTILATOR MARKET FOR GERIATRIC, 2019-2027 ($MILLION)
FIGURE 19.U.S. PORTABLE VENTILATOR MARKET FOR HOSPITAL AND CLINICS, 2019-2027 ($MILLION)
FIGURE 20.U.S. PORTABLE VENTILATOR MARKET FOR AMBULATORY CARE CENTER, 2019-2027 ($MILLION)
FIGURE 21.U.S. PORTABLE VENTILATOR MARKET FOR HOME CARE, 2019-2027 ($MILLION)
FIGURE 22.BD: NET SALES, 2017–2019 ($MILLION)
FIGURE 23.BD: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 24.BD: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 25.DRAGER: REVENUE, 2017–2019 ($MILLION)
FIGURE 26.DRAGER: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 27.GETINGE: REVENUE, 2017–2019 ($MILLION)82
FIGURE 28.GETINGE: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 29.GETINGE: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 30.PHILIPS: NET SALES, 2017–2019 ($MILLION)
FIGURE 31.PHILIPS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 32.PHILIPS: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 33.MEDTRONIC: NET SALES, 2017–2019 ($MILLION)
FIGURE 34.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 35.MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 36.SMITHS: NET SALES, 2017–2019 ($MILLION)101
FIGURE 37.SMITHS: REVENUE SHARE, BY DIVISION, 2019 (%)
FIGURE 38.SMITHS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 39.RESMED: NET SALES, 2017–2019 ($MILLION)106
FIGURE 40.RESMED: REVENUE SHARE, BY DIVISION, 2019 (%)
FIGURE 41.RESMED: REVENUE SHARE, BY REGION, 2019 (%)
